دورية أكاديمية
SleepWell24, a Smartphone Application to Promote Adherence to Positive Airway Pressure Therapy: Feasibility and Acceptability in a Randomized Controlled Trial.
| العنوان: | SleepWell24, a Smartphone Application to Promote Adherence to Positive Airway Pressure Therapy: Feasibility and Acceptability in a Randomized Controlled Trial. |
|---|---|
| المؤلفون: | Petrov ME; Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, AZ, USA., Epstein DR; College of Health Solutions, Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, USA., Krahn L; Center for Sleep Medicine, Department of Pulmonary Medicine, Department of Psychiatry and Psychology, Mayo Clinic, Scottsdale, USA., Todd M; Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, AZ, USA., Park JG; Center for Sleep Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA., St Louis EK; Center for Sleep Medicine, Division of Pulmonary and Critical Care Medicine, Departments of Neurology and Medicine, Mayo Clinic College of Medicine and Science, Rochester, La Crosse, WI, USA., Morgenthaler TI; Center for Sleep Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA., Hoffmann CM; Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, AZ, USA., Hasanaj K; College of Health Solutions, Arizona State University, Phoenix, AZ, USA., Hollingshead K; College of Health Solutions, Arizona State University, Phoenix, AZ, USA., Yu TY; College of Health Solutions, Arizona State University, Phoenix, AZ, USA., Buman MP; College of Health Solutions, Arizona State University, Phoenix, AZ, USA. |
| المصدر: | Behavioral sleep medicine [Behav Sleep Med] 2024 Jul-Aug; Vol. 22 (4), pp. 420-432. Date of Electronic Publication: 2023 Nov 30. |
| نوع المنشور: | Journal Article; Randomized Controlled Trial |
| اللغة: | English |
| بيانات الدورية: | Publisher: Routledge Country of Publication: England NLM ID: 101149327 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-2010 (Electronic) Linking ISSN: 15402002 NLM ISO Abbreviation: Behav Sleep Med Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2009- : London : Routledge Original Publication: Mahwah, N.J. : Lawrence Erlbaum Associates, c2003- |
| مواضيع طبية MeSH: | Mobile Applications* , Smartphone* , Sleep Apnea, Obstructive*/therapy , Sleep Apnea, Obstructive*/physiopathology , Feasibility Studies* , Continuous Positive Airway Pressure*/instrumentation , Continuous Positive Airway Pressure*/methods , Patient Compliance*/statistics & numerical data, Humans ; Female ; Male ; Middle Aged ; Single-Blind Method ; Aged ; Adult |
| مستخلص: | Objective: To investigate the feasibility and acceptability of SleepWell24 , a multicomponent, evidence-based smartphone application, to improve positive airway pressure therapy (PAP) adherence, among patients with obstructive sleep apnea (OSA) naive to PAP. Methods: In a single-blind randomized controlled trial, SleepWell24 , with a companion activity monitor was compared to usual care plus the activity monitor and its associated app. SleepWell24 provides objective feedback on PAP usage and sleep/physical activity patterns, and chronic disease management. Patients were recruited from two sleep medicine centers and followed over the first 60 days of PAP. Feasibility and acceptability were measured by recruitment/retention rates, app usage, differences in post-trial Treatment Evaluation Questionnaire (TEQ) scores, and patient interviews. Exploratory, intent-to-treat logistic and linear mixed models estimated PAP adherence and clinical outcomes. Results: Of 103 eligible participants, 87 were enrolled ( SleepWell24 n = 40, control n = 47; mean 57.6y [SD = 12.3], 44.8% female). Retention was ≥95% across arms. There were no significant differences in TEQ scores. SleepWell24 participants engaged with the app on 62.9% of trial days. PAP use was high across both arms ( SleepWell24 vs. Control: mean hours 5.98 vs. 5.86). There were no differences in PAP adherence or clinical outcomes. Conclusions: SleepWell24 was feasible and acceptable among PAP-naive patients with OSA. Clinical Trial Registration: NCT03156283https://www.clinicaltrials.gov/study/NCT03156283. |
| معلومات مُعتمدة: | R21 NR016046 United States NR NINR NIH HHS |
| سلسلة جزيئية: | ClinicalTrials.gov NCT03156283 |
| تواريخ الأحداث: | Date Created: 20231130 Date Completed: 20240611 Latest Revision: 20240613 |
| رمز التحديث: | 20240613 |
| مُعرف محوري في PubMed: | PMC11136882 |
| DOI: | 10.1080/15402002.2023.2289442 |
| PMID: | 38032115 |
| قاعدة البيانات: | MEDLINE |
PDF full text from Publisher | تدمد: | 1540-2010 |
|---|---|
| DOI: | 10.1080/15402002.2023.2289442 |